The efficacy and safety of erlotinib compared with chemotherapy in previously treated NSCLC: A meta-analysis

The efficacy and safety of erlotinib compared with chemotherapy in previously treated NSCLC: A meta-analysis

BackgroundAn increasing number of patients with advanced non-small cell lung cancer (NSCLC) have a poor prognosis and develop progressive disease after receiving conventional treatments. In recent years, several novel therapies have been approved for later lines of therapy of previously treated NSCL...

Full description

Bibliographic Details
Main Authors: Fazong Wu, Jingjing Song, Zhongwei Zhao, Xufang Huang, Jianting Mao, Jianfei Tu, Minjiang Chen, Weiqian Chen, Shiji Fang, Liyun Zheng, Xiaoxi Fan
Format: Article
Language:English
Published: AIMS Press 2019-08-01
Series:Mathematical Biosciences and Engineering
Subjects:
nsclc
erlotinib
pretreated patients
meta-analysis
Online Access:https://www.aimspress.com/article/10.3934/mbe.2019398?viewType=HTML

Internet

https://www.aimspress.com/article/10.3934/mbe.2019398?viewType=HTML

Similar Items